Gebbia, V <br/><br/>
A prospective randomized trial of thymopentin versus granulocyte--colony stimulating factor with or without thymopentin in the prevention of febrile episodes in cancer patients undergoing highly cytotoxic chemotherapy.  [electronic resource] 

 -  Anticancer research   
 - 731-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0250-7005 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Endometrial Neoplasms--drug therapy<br/>Female<br/>Fever--prevention & control<br/>Granulocyte Colony-Stimulating Factor--adverse effects<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Incidence<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Mycoses--epidemiology<br/>Neoplasms--drug therapy<br/>Neutropenia--epidemiology<br/>Ovarian Neoplasms--drug therapy<br/>Prospective Studies<br/>Stomach Neoplasms--drug therapy<br/>Thymopentin--adverse effects